COWEN AND COMPANY, LLC - ADVERUM BIOTECHNOLOGIES INC ownership

ADVERUM BIOTECHNOLOGIES INC's ticker is ADVM and the CUSIP is 00773U108. A total of 117 filers reported holding ADVERUM BIOTECHNOLOGIES INC in Q4 2019. The put-call ratio across all filers is 0.32 and the average weighting 0.6%.

Quarter-by-quarter ownership
COWEN AND COMPANY, LLC ownership history of ADVERUM BIOTECHNOLOGIES INC
ValueSharesWeighting
Q4 2021$1,711,000
+18.8%
972,176
+595.5%
0.16%
-34.0%
Q3 2020$1,440,000
-57.0%
139,781
-12.8%
0.24%
-57.7%
Q2 2020$3,345,000
+56.6%
160,216
-26.7%
0.56%
+13.5%
Q1 2020$2,136,000
-21.6%
218,624
-7.6%
0.49%
+106.8%
Q4 2019$2,725,000
+136150.0%
236,583
+688.6%
0.24%
+23600.0%
Q3 2019$2,00030,0000.00%
Other shareholders
ADVERUM BIOTECHNOLOGIES INC shareholders Q4 2019
NameSharesValueWeighting ↓
Sonic Fund II, L.P. 6,552,068$14,218,0008.03%
Versant Venture Management, LLC 5,068,233$10,998,0004.55%
K2 PRINCIPAL FUND, L.P. 1,653,874$3,589,0000.29%
RTW INVESTMENTS, LP 7,483,757$16,240,0000.24%
Avoro Capital Advisors LLC 6,950,000$15,082,0000.24%
Artal Group S.A. 3,000,000$6,510,0000.15%
ALGERT GLOBAL LLC 231,490$502,0000.07%
Virtus ETF Advisers LLC 57,768$125,0000.06%
Pinz Capital Management, LP 53,600$116,0000.05%
TWIN FOCUS CAPITAL PARTNERS, LLC 100,000$217,0000.05%
View complete list of ADVERUM BIOTECHNOLOGIES INC shareholders